Emmanuelle David

767 total citations
15 papers, 633 citations indexed

About

Emmanuelle David is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Emmanuelle David has authored 15 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Rheumatology. Recurrent topics in Emmanuelle David's work include Sarcoma Diagnosis and Treatment (7 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Bone Tumor Diagnosis and Treatments (4 papers). Emmanuelle David is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Cytokine Signaling Pathways and Interactions (6 papers) and Bone Tumor Diagnosis and Treatments (4 papers). Emmanuelle David collaborates with scholars based in France, Canada and United States. Emmanuelle David's co-authors include Dominique Heymann, Françoise Rédiní, Frédéric Blanchard, Pierre Guihard, Bénédicte Brounais, Carl D. Richards, Yannic Danger, Régis Brion, Sylvie Chevalier and Hugues Gascan and has published in prestigious journals such as Philosophical Transactions of the Royal Society B Biological Sciences, American Journal Of Pathology and International Journal of Cancer.

In The Last Decade

Emmanuelle David

14 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuelle David France 8 252 186 153 145 109 15 633
Bénédicte Brounais France 7 347 1.4× 223 1.2× 182 1.2× 152 1.0× 57 0.5× 11 714
Chaoxiang Shui United States 7 444 1.8× 232 1.2× 60 0.4× 115 0.8× 70 0.6× 10 785
Guiti Z. Eghbali-Fatourechi United States 7 310 1.2× 190 1.0× 46 0.3× 80 0.6× 69 0.6× 7 719
Joan García‐López Spain 14 259 1.0× 210 1.1× 263 1.7× 69 0.5× 47 0.4× 20 1.1k
Yohei Yamamoto Japan 13 176 0.7× 87 0.5× 160 1.0× 39 0.3× 109 1.0× 25 604
Leslie Kurtzberg United States 11 437 1.7× 149 0.8× 46 0.3× 185 1.3× 73 0.7× 14 780
Toshiyuki Kitaori Japan 9 220 0.9× 129 0.7× 94 0.6× 101 0.7× 25 0.2× 17 805
Soraya Carrancio Spain 15 298 1.2× 143 0.8× 160 1.0× 70 0.5× 37 0.3× 33 1.0k
Barbara Toffoletto Italy 14 483 1.9× 199 1.1× 131 0.9× 75 0.5× 62 0.6× 21 890
Séverine Couillaud France 10 414 1.6× 376 2.0× 58 0.4× 78 0.5× 82 0.8× 12 682

Countries citing papers authored by Emmanuelle David

Since Specialization
Citations

This map shows the geographic impact of Emmanuelle David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle David more than expected).

Fields of papers citing papers by Emmanuelle David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle David. The network helps show where Emmanuelle David may publish in the future.

Co-authorship network of co-authors of Emmanuelle David

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle David. A scholar is included among the top collaborators of Emmanuelle David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle David. Emmanuelle David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
David, Emmanuelle, et al.. (2025). Systematic functional assessment of anti-phage systems in their native host. Philosophical Transactions of the Royal Society B Biological Sciences. 380(1934). 20240067–20240067. 1 indexed citations
2.
David, Emmanuelle, et al.. (2020). Phase I dose escalation study of 12b80 (hydroxybisphosphonate linked doxorubicin) in naturally occurring osteosarcoma. Oncotarget. 11(46). 4281–4292. 5 indexed citations
3.
David, Emmanuelle, Sébastien Cagnol, Julien Taurelle, et al.. (2019). 12b80 – Hydroxybisphosphonate Linked Doxorubicin: Bone Targeted Strategy for Treatment of Osteosarcoma. Bioconjugate Chemistry. 30(6). 1665–1676. 19 indexed citations
4.
David, Emmanuelle, Aurélien Vidal, Sophie Besse, et al.. (2013). 99mTc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model. EJNMMI Research. 3(1). 40–40. 7 indexed citations
5.
David, Emmanuelle, Soraya Saïagh, Sylvain Bercegeay, et al.. (2013). New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance. Laboratory Investigation. 93(10). 1100–1114. 36 indexed citations
6.
David, Emmanuelle, Soraya Saïagh, Sylvain Bercegeay, et al.. (2013). New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance. Bone Abstracts.
7.
David, Emmanuelle, Franck Tirode, Marc Baud’huin, et al.. (2012). Oncostatin M Is a Growth Factor for Ewing Sarcoma. American Journal Of Pathology. 181(5). 1782–1795. 34 indexed citations
8.
Danger, Yannic, Bénédicte Brounais, Emmanuelle David, et al.. (2012). Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on Oncostatin M signaling. Bone. 50. S67–S67. 6 indexed citations
9.
Guihard, Pierre, Yannic Danger, Bénédicte Brounais, et al.. (2012). Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling. Stem Cells. 30(4). 762–772. 393 indexed citations
10.
David, Emmanuelle, Aurélien Vidal, Philippe Auzeloux, et al.. (2011). Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies. Investigational New Drugs. 30(4). 1782–1790. 19 indexed citations
11.
David, Emmanuelle, Frédéric Blanchard, Marie‐Françoise Heymann, et al.. (2011). The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets. Sarcoma. 2011. 1–8. 57 indexed citations
12.
David, Emmanuelle, Pierre Guihard, Bénédicte Brounais, et al.. (2010). Direct anti‐cancer effect of oncostatin M on chondrosarcoma. International Journal of Cancer. 128(8). 1822–1835. 34 indexed citations
13.
David, Emmanuelle, Pierre Guihard, Bénédicte Brounais, et al.. (2010). Direct anti-cancer effect of oncostatin M on chondrosarcoma. Bone. 48(1). S36–S36. 1 indexed citations
14.
Brounais, Bénédicte, Emmanuelle David, Céline Chipoy, et al.. (2009). Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells. Bone. 44(5). 830–839. 20 indexed citations
15.
Brounais, Bénédicte, Emmanuelle David, Valérie Trichet, et al.. (2009). Long term oncostatin m treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells. Bone. 44. S301–S302. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026